The most common include: Nausea, vomiting, diarrhea, constipation, abdominal pain Headache, dizziness, fatigue Indigestion, upset stomach, acid reflux Decreased appetite Injection site reactions Side effects are usually mild to moderate and tend to decrease over time

CrossRef GLP1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study Jisu Park, Ju Hwan Kim, Yoon Seob Kim, Gyeongmin Lim, Hong Ji Song, Sang Youl Rhee, Seonghoon Hwang, Daeun Cho, Minyoung Kim, BoYeon Kim, Chang Won Jeong, DaeYeon Kim, Hang A Park, MinHo Kim, Seong Hwan Kim, WonWoo Seo, Woo Jin Kim, Young Sung Suh, Ra Diabetes, Obesity and Metabolism.2026;[Epub] CrossRef GlucagonLike Peptide1 Receptor Agonists and Risk of Mental Health Disorders in Type 2 Diabetes: Active Comparator, New User Cohort Study Chungsoo Kim, Seonji Kim, Dong Yun Lee, Eugene Han, Yongho Lee, Seng Chan You Diabetes, Obesity and Metabolism.2026;[Epub] CrossRef Avoiding Malnutrition in the Era of Glucagon-Like Peptide-1 Medications: Emerging Evidence and Opportunities for Integrated Nutrition Care Paola Mogna-Pelez, Marta Guasch-Ferr The Journal of Nutrition.2026

[20] [9] If severe abdominal pain develops during GLP-1 agonist treatmentparticularly if it persists for several hours or is accompanied by repeated vomitingpatients should stop taking the medication and seek immediate medical assessment
Watch for Red Flags Avoid deeply discounted products, vendors missing contact pages, or formulas lacking explicit dosage breakdowns per serving